Covered recipient · General Payments record
ROJI MENON
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$2,652.13
- Reported across 124 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.11 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $137.90 | 2 |
| Lilly USA, LLC | $94.50 | 5 |
| ABBVIE INC. | $53.28 | 3 |
| PFIZER INC. | $48.50 | 3 |
| Amgen Inc. | $36.62 | 2 |
| GlaxoSmithKline, LLC. | $18.85 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.81 | 1 |
| Astellas Pharma US Inc | $16.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.64 | 03/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203073404 | CMS |
| ABBVIE INC. | $16.08 | 05/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203073406 | CMS |
| ABBVIE INC. | $14.56 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203073408 | CMS |
| Amgen Inc. | $20.32 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228469764 | CMS |
| Amgen Inc. | $16.30 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228469762 | CMS |
| Astellas Pharma US Inc | $16.65 | 01/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238727692 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.47 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207081506 | CMS |
| AstraZeneca Pharmaceuticals LP | $119.43 | 04/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206978122 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.81 | 03/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1222725327 | CMS |
| GlaxoSmithKline, LLC. | $18.85 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1191426934 | CMS |
| Lilly USA, LLC | $21.89 | 03/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186847235 | CMS |
| Lilly USA, LLC | $16.27 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186921370 | CMS |
| Lilly USA, LLC | $18.72 | 06/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186908002 | CMS |
| Lilly USA, LLC | $21.28 | 08/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186897419 | CMS |
| Lilly USA, LLC | $16.34 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186847233 | CMS |
| PFIZER INC. | $14.44 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228999668 | CMS |
| PFIZER INC. | $16.27 | 01/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228996057 | CMS |
| PFIZER INC. | $17.79 | 02/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229831883 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.